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Background: Chronic kidney disease (CKD) is increasing in prevalence world-wide with the largest growth being in
the elderly. The aim of this study was to examine the prevalence of CKD in a geriatric outpatient clinic within
a tertiary hospital and its association with anaemia and mortality with a focus on the referral patterns
towards nephrologists.
Methods: Retrospective study utilising administrative databases. The cohort was defined as all patients that
attended the geriatric outpatient clinics of a single tertiary hospital within the first 3 months of 2006. Patients were
followed for 18 months for mortality and referral to a nephrologist.
Results: The mean Glomerular filtration rate (eGFR) of the 439 patients was 67.4 ± 29.1 mL/min/1.73 m2
(44% <60 mL/min/1.73 m2). 11.8% had a haemoglobin < 110 g/L, with anaemia being significantly associated with
kidney function in those with a eGFR < 60 mL/min/1.73 m2 (p = 0.0092). Kidney function and anaemia were
significantly associated with mortality on multivariate analysis (p = 0.019 and p= 0.0074). After 18 months,
8.8% of patients with CKD were referred to a nephrologist.
Conclusion: Despite a high prevalence of CKD in patients attending a geriatric outpatient clinic and its association
with anaemia and mortality, few of these patients were referred to a nephrologist. An examination of the reasons
behind this bias is required.
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Chronic kidney disease (CKD) is a growing problem due
to our ageing population, many of who have increased
comorbidities [1]. Cross-sectional studies in the general
population demonstrate that CKD is seen in up to
15.3%, including 39% of those over the age of 65 years
[1-3]. Previously restrictive selection criteria for com-
mencement of dialysis in a patient have over the years
been relaxed, for a number of reasons. As a consequence* Correspondence: neil.boudville@uwa.edu.au
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reproduction in any medium, provided the orprevalent dialysis numbers are increasing with its asso-
ciated considerable cost [1,4].
In addition to the cost of dialysis, earlier stages of
CKD are associated with increased morbidity and mor-
tality [5,6]. A common complication, even with mild to
moderate CKD, is anaemia [7,8]. This has significant
effects on the quality of life of an individual that can be
improved through the use of epoetins [9].
There is a perception that medical professionals caring
for the elderly are potentially biased against referring
patients to Nephrologists [10,11]. This may be partly
due to the strict selection criteria that existed, when
renal replacement therapy initially began, for the com-
mencement of dialysis which often included an age limit
[11]. In addition, some health care professionals mayal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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better served by not going onto dialysis.
Our aim was to examine the prevalence of CKD in a
tertiary Geriatrics outpatient clinic, in addition to its as-
sociation with anaemia and mortality, and the referral
patterns of Geriatricians to Nephrologists.Methods
This was a retrospective study that included all patients
over the age of 65 years who were reviewed in the out-
patient clinics of the Department of Aged Care and
Rehabilitation in Sir Charles Gairdner Hospital (SCGH)
during the first quarter of 2006. This is the second lar-
gest teaching hospital within Western Australia with
clinics including general geriatrics clinics, and specia-
lised memory and falls clinics. The Department of Aged
Care and Rehabilitation included 6 Specialists. There
were 5 Specialists in the Department of Renal Medicine
in SCGH with 20 overall in Western Australia. Patients
with end-stage kidney disease were excluded. This study
was approved by the hospital Human Research and
Ethics Committee.
The hospital laboratory database (Pathwest) was then
examined for the results of blood tests performed on
these patients. In addition, medical records were
reviewed. Variables recorded included demographic data,
serum creatinine, haemoglobin, and iron studies.
Referral to a nephrologist within the next 18 months
was then recorded through review of the patients’ med-
ical records, CKD databases, and review of individual
nephrologist databases. Survival after 18 months was
also recorded.Table 1 Baseline demographics
65-75 years old
(n = 87)
Male (%) 42 (47.1%)
Estimated Glomerular Filtration Rate (eGFR)
(mL/min/1.73 m2)
74.0 ± 26.7
Chronic Kidney Disease (CKD) stage (eGFR) (%)
1 (>90 mL/min/1.73 m2) 33.3
2 (60–90 mL/min/1.73 m2) 34.5
3 (30–60 mL/min/1.73 m2) 26.4
4 (15–30 mL/min/1.73 m2) 2.3
5 (<15 mL/min/1.73 m2) 3.5
Haemoglobin (g/dL) 13.0 ± 1.7
Mean Cell Volume (fL) 91.3 ± 4.9
Vitamin B12 (pmol/L) 410.9 ± 203.1
Red cell folate (nmol/L) 1087.9 ± 653.8
Ferritin (μg/L) 251.9 ± 491.6
Transferrin saturation (%) 21.6 ± 9.0Creatinine was measured using a kinetic colourimetric
assay (Jaffe method) analysed on the Roche Hitachi 917
analyser (Roche Diagnostic GmbH, Mannheim, Germany).
Total CV’s for this assay are 6.6% at 0.8 mg/dL, and 4.1%
at 5.5 mg/dL. Glomerular filtration rate (eGFR) was esti-
mated from serum creatinine utilising the 4-variable
Modification of Diet in Renal Disease study equation [12].
All variables are reported as mean ± standard devi-
ation, unless otherwise stated. Normality of variables
was examined and if required transformation to im-
prove normality was performed. Patients were
grouped based upon their age into one of 3
categories – 65–75 years old; 75–85 years old; and
over 85 years old. Simple linear regression was uti-
lised to assess the relationship between haemoglobin
and eGFR. Cox proportional hazards regression were
used to examine the association between mortality
and kidney function and haemoglobin on univariate
and multivariate analysis. Other variables were exam-
ined to detect an association with mortality
including age, gender, and iron status. Variables with
a p-value < 0.10 on univariate analysis was added in
the multivariate model. STATA 11.0 (Stata Corpor-
ation, College Station, Texas, USA) was used for the
analysis.
Results
439 patients were reviewed during the first 3 months of
2006 and had biochemical testing performed (Table 1).
A total of 867 patients were reviewed in this clinic dur-
ing the baseline period. The mean age of the total 867
patients was 80.2 ± 8.5 years, compared to 80.7 ± 8.9 years
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13.0 ± 1.8 12.6 ± 1.9 12.9 ± 1.8
91.5 ± 6.7 92.8 ± 6.1 91.9 ± 6.2
409.3 ± 320.0 436.8 ± 360.2 418.1 ± 318.3
1477.6 ± 940.9 1082.1 ± 871.3 1294.2 ± 898.3
221.3 ± 342.9 169.3 ± 228.2 212.4 ± 345.9
17.2 ± 10.2 16.9 ± 8.8 17.9 ± 9.7
Table 2 Univariate and multivariate logistic regression of









Age (years) 0.009 0.36
Gender 0.03 0.06
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a serum creatinine measurement.
CKD
44% of patients had a eGFR < 60 mL/minute/1.73 m2,
with 20%, 5% and 1.1% having a eGFR <45 mL/min/
1.73 m2, <30 mL/min/1.73 m2 and <15 mL/min/1.73 m2
respectively. The mean eGFR for people aged 65–
75 years was 74.0 ± 26.7 mL/min/1.73 m2, 75–85 years
was 69.4 ± 31.8 mL/min/1.73 m2, and for those over
85 years was 59.7 ± 24.2 mL/min/1.73 m2.
Anaemia
11.8% of this sample had a haemoglobin less than 110 g/
L, with 4.3% having a haemoglobin less than 100 g/L. Of
those with a eGFR < 60 mL/min/1.73 m2, 17.2% had a
haemoglobin <110 g/L and 6.5% had a haemoglobin
<100 g/L. Haemoglobin was not significantly associated
with eGFR on linear regression in the total population
(p = 0.065), but it did reach significance on examining
those with a eGFR < 60 mL/min/1.73 m2 (Figure 1,
p = 0.0092). Mean haemoglobin was similar between
those aged 65-75 years, 75-85 years and over 85 years at
130 ± 17 g/L, 130 ± 17 g/L and 126 ± 19 g/L respectively.
The mean ferritin was 94 ± 154 ng/mL with a transferrin
saturation of 17.9 ± 9.7%.
Mortality
After 18 months of follow-up, 16.0% of the sample had
died, compared to 10.3% of the total 867 patients that
attended the clinics. Death was significantly associated
with eGFR and anaemia on univariate analysis, p = 0.0074









Figure 1 Scatter plot and regression line for estimated
Glomerular filtration rate (eGFR) versus haemoglobin in those
participants with a eGFR<60 mL/min/1.73 m2.logistic regression, both eGFR and haemoglobin remained
independently associated with mortality, p = 0.0047.
Survival analysis indicated that CKD stage 4 was asso-
ciated with a 19.7 fold increased hazard of mortality than
CKD stage 1, p = 0.012.Referral to Nephrologist
After 18 months of follow-up, 17 patients were referred
to a nephrologist. This represents 8.8% of those patients
with known/identified CKD on blood test. 34 patients
had, at baseline, either a haemoglobin <100 g/L or a
eGFR > 60 mL/min/1.73 m2. The mean eGFR of those
patients referred to a nephrologist was 27.1 ± 14.2 mL/
min/1.73 m2, with 10 (58.8%) having a eGFR < 60 mL/
min/1.73 m2 (see Table 3). Haemoglobin, age and eGFR
did not predict referral to a nephrologist, p = 0.93, 0.95
and 0.055 respectively.Discussion
Chronic kidney disease is associated with increased mor-
bidity, mortality, haematological and biochemical abnor-
malities. Increasing age is associated with an increased
prevalence of CKD [3]. There is evidence however that
there may be a pattern of restricted referral to Nephrolo-
gists from medical practitioners caring for the elderly
[10,11]. Our study demonstrated that CKD is common
in patients over 65 attending a tertiary geriatrics out-
patient clinic. CKD was associated with anaemia and
mortality but despite this few patients were referred to a
nephrologist.
Mortality has been demonstrated to be inversely asso-
ciated with kidney function, with the risk increased once
the eGFR is below 60 mL/min/1.73 m2 [5]. Interventions
that can slow progressive renal failure exist but some-
times require input from a nephrologist [13,14]. In
addition a nephrologist can assist with the optimal man-
agement of mineral bone disease that also occurs with
increasing prevalence once eGFR < 60 mL/min/1.73 m2
[15-17].
Anaemia can be directly related to CKD, with its
increased risk commencing once the eGFR reaches
60 mL/min/1.73 m2 or less [7,8]. This was demonstrated
Table 3 Age and Chronic Kidney Disease (CKD) stage of patients referred to a nephrologist
CKD stage (eGFR) Age= 65–75 years Age= 75–85 years Age> 85 years
1 (>90 mL/min/1.73 m2) 0% 0 % 0%
2 (60–90 mL/min/1.73 m2) 0% 0% 0%
3 (30–60 mL/min/1.73 m2) 0% 29.4% 23.5%
4 (15–30 mL/min/1.73 m2) 5.9% 17.6% 5.9%
5 (<15 mL/min/1.73 m2) 11.8% 5.9% 0%
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population. Quality of life can be improved considerably,
and blood transfusions avoided, with the prescription of
erythropoiesis stimulating agents [18,19]. In Australia,
government subsidised prescription of these agents is
restricted to Nephrologists and Haematologists.
The prevalence of CKD with a eGFR < 60 mL/min/
1.73 m2 in our geriatric outpatient population was 44%,
with an increased rate with increasing age. This is con-
sistently greater than the prevalence of CKD in other
cohorts - 14.7% of over 65 year old residents of long-
term care facilities, 15.6% in outpatient clinics, 17.5% in
a community-based laboratory, and 22.4% over 65 year
olds in a primary care setting [5,20-22]. Other studies
have shown that a considerable proportion of patients
do not receive evidence based intervention for CKD in
non-nephrology practices [23]. Suggesting that referral
of this population to a Nephrologist may assist in the
diagnosis of the aetiology of the CKD and to ensure that
optimal management was being prescribed.
Contrary to the belief of some medical practitioners,
commencement of dialysis in the elderly may be asso-
ciated with an improved quantity and quality of life [24].
As a consequence of multiple factors, the greatest in-
crease in new dialysis patients in Australia and the UK
are in the over 65 age group [1,25]. Late referral to a
nephrologist may delay optimal preparation for dialysis
and is associated with worse outcomes, prompting na-
tional and international Guidelines for early referral of
CKD patients to Nephrologists [24,26,27].
Despite this there was a surprisingly low referral rate
of patients with CKD to a Nephrologist, 50% of the
recommended numbers based upon Kidney Health
Australia guidelines of eGFR < 30 mL/min/1.73 m2 or
Haemoglobin < 100 g/L with eGFR= 30-60 mL/min/
1.73 m2 [26,28,29]. It is unclear why this practice pattern
exists [28]. It may be related to a previous bias towards
not dialysing the elderly or the belief that dialysis is not
appropriate or in the best interests of the elderly.
The Nephrology workforce in SCGH and in the State
is similar to the rest of Australia, with 72.7 end-stage
kidney disease (ESKD) patients per full-time equivalent
nephrologist in WA compared with 60.3 for Australia
[30]. In addition the demographics of ESKD patients in
WA is similar to the rest of Australia with 453 Dialysispatients per million population, compared with 471 in
Australia [31]. The peak in the age group for prevalent
dialysis patients in WA and Australia is also the same at
65 to 74 years old [31]. This suggests that results from
this paper may be generalizable to the rest of Australia.
Limitations include its retrospective nature. While a
complete list of people attending the geriatrics outpati-
ents clinic during the baseline period was obtained, data
was only obtained on those patients that were having
blood tests performed for clinical reasons. This bias is
likely to overestimate the true prevalence rates.
Additionally, an examination was not made to see if the
CKD patients identified were already on optimal treat-
ment to slow progressive kidney failure. Regardless,
those with anaemia and advanced CKD would probably
benefit from referral to a nephrologist. Other metabolic
complications of CKD were not examined due to the
lack of information as measurement of these parameters
(e.g. serum phosphate) were not part of usual clinical
practice in these clinics.
Conclusions
We have documented a high prevalence of CKD in
patients attending a tertiary hospital geriatrics outpatient
clinic. The CKD was associated with an increased risk of
mortality and anaemia. The referral patterns of the
supervising practitioners demonstrated restricted con-
sultation with nephrologists, despite the potential bene-
fits to the patient. This requires further investigation to
examine the reasons behind these referral patterns in
order to be able to implement interventions to increase
referral if it is deemed appropriate.
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